IBEX Therapeutics, a Swiss company specialised in therapies based on biological products derived from plant extracts.
Founded in 2021 by 4 co-founders with solid experience in the pharmaceutical industry.
Subsidiary company of PHARMALP SA used to create an opportunity to leverage a patent by investing in the development of a pharmaceutical product.
Mission: To bring the first product to market within 3 years with a solid proof of concept.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Route Des Eterpys 22, Phytoark,switzerland
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://ibextx.ch/en/
- HQ
- Conthey, Valais
Ibex Therapeutics Questions
Ibex Therapeutics's website is https://ibextx.ch/en/
Ibex Therapeutics's LinkedIn profile is https://ch.linkedin.com/company/ibex-tx
Ibex Therapeutics has
4 employees.
View email and phone details for 4
employees at Ibex Therapeutics.
Ibex Therapeutics's industry is
Pharmaceutical Manufacturing
Ibex Therapeutics's top competitors are
Helix Biotech, Inc.,
Nuvamid,
Limula,
Rem Analytics,
Anemos Therapeutics,
Bioscibex,
Immunskills Sa,
Immunoshield Therapeutics,
Hawk Biosystems,
Lys Therapeutics.
Ibex Therapeutics's categories are Pharmaceutical Manufacturing
Ibex Therapeutics's founding year is 2021
